Alnylam Pharmaceuticals Receives EC Approval for AMVUTTRA® for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Alnylam Pharmaceutical's News Today is Great

Before we get to the press release from Alnylam Pharmaceuticals we remind that tomorrow, Tuesday, June 10, 2025,  Akero Therapeutics’ management will present at Goldman Sachs 46th Annual Global Healthcare Conference at 2:40 pm Et.

The presentation will be available through the investor relations section of the company’s website at www.akerotx.com.

An archived replay will be available for those who missed the conference . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.